ACADSB
Basic information
Region (hg38): 10:123008979-123058290
Links
Phenotypes
GenCC
Source:
- 2-methylbutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
- 2-methylbutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
- 2-methylbutyryl-CoA dehydrogenase deficiency (Moderate), mode of inheritance: AR
- 2-methylbutyryl-CoA dehydrogenase deficiency (Supportive), mode of inheritance: AR
- 2-methylbutyryl-CoA dehydrogenase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
2-methylbutyryl-CoA dehydrogenase deficiency | AR | General | The clinical relevance of the condition is unclear, though some have stated that special attention may be necessary in situations involving potential metabolic decompensation | Biochemical | 10832746; 12837870; 16317551; 17883863; 17945527; 20547083; 21290185 |
ClinVar
This is a list of variants' phenotypes submitted to
- Deficiency_of_2-methylbutyryl-CoA_dehydrogenase (167 variants)
- not_provided (29 variants)
- ACADSB-related_disorder (17 variants)
- not_specified (8 variants)
- Inborn_genetic_diseases (4 variants)
- See_cases (2 variants)
- Microcephaly (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACADSB gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001609.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 28 | 36 | ||||
missense | 71 | 85 | ||||
nonsense | 8 | |||||
start loss | 1 | 1 | ||||
frameshift | 12 | |||||
splice donor/acceptor (+/-2bp) | 11 | |||||
Total | 11 | 29 | 75 | 32 | 6 |
Highest pathogenic variant AF is 0.000778146
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACADSB | protein_coding | protein_coding | ENST00000358776 | 11 | 49333 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.66e-11 | 0.263 | 125537 | 0 | 211 | 125748 | 0.000839 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0697 | 230 | 227 | 1.01 | 0.0000110 | 2789 |
Missense in Polyphen | 89 | 91.567 | 0.97197 | 1143 | ||
Synonymous | 0.538 | 78 | 84.3 | 0.925 | 0.00000447 | 818 |
Loss of Function | 0.910 | 19 | 23.8 | 0.799 | 0.00000109 | 312 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00309 | 0.00309 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00272 | 0.00272 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000757 | 0.000756 |
Middle Eastern | 0.00272 | 0.00272 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Has greatest activity toward short branched chain acyl- CoA derivative such as (s)-2-methylbutyryl-CoA, isobutyryl-CoA, and 2-methylhexanoyl-CoA as well as toward short straight chain acyl-CoAs such as butyryl-CoA and hexanoyl-CoA. Can use valproyl- CoA as substrate and may play a role in controlling the metabolic flux of valproic acid in the development of toxicity of this agent.;
- Pathway
- Fatty acid degradation - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Valproic Acid Pathway, Pharmacokinetics;Long chain acyl-CoA dehydrogenase deficiency (LCAD);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Trifunctional protein deficiency;Carnitine palmitoyl transferase deficiency (II);Very-long-chain acyl coa dehydrogenase deficiency (VLCAD);Medium chain acyl-coa dehydrogenase deficiency (MCAD);Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency);Fatty acid Metabolism;Maple Syrup Urine Disease;Valproic Acid Metabolism Pathway;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Glutaric Aciduria Type I;Ethylmalonic Encephalopathy;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Carnitine palmitoyl transferase deficiency (I);Valproic acid pathway;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;Saturated fatty acids beta-oxidation;Metabolism;Mono-unsaturated fatty acid beta-oxidation;Valine, leucine and isoleucine degradation;Propanoate metabolism;Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation;isoleucine degradation
(Consensus)
Recessive Scores
- pRec
- 0.275
Intolerance Scores
- loftool
- 0.294
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.73
Haploinsufficiency Scores
- pHI
- 0.507
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.872
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acadsb
- Phenotype
Gene ontology
- Biological process
- fatty acid metabolic process;branched-chain amino acid catabolic process;oxidation-reduction process
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding